- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Impax Laboratories Inc
Add to PortfolioIPXL:US
21.2300 USD 0.0300 0.14%As of 20:10:00 ET on 05/25/2012.
Snapshot for Impax Laboratories Inc (IPXL)
| Open: | 21.2300 | Day's Range: | 21.1300 - 21.3500 | Volume: | 193,446 | Bid: | 21.2000 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 21.2000 | 52wk Range: | 14.4600 - 27.2600 | 1-Yr Rtn: | -21.89% | Ask: | 21.2300 |
Key Statistics for IPXL
| Current P/E Ratio (ttm) | 15.3841 |
|---|---|
| Estimated P/E (12/2012) | 11.6970 |
| Earnings Per Share (USD) (ttm) | 1.3800 |
| Est. EPS (USD) (12/2012) | 1.8150 |
| Est. PEG Ratio | 0.4974 |
| Market Cap (M USD) | 1,422.58 |
| Shares Outstanding (M) | 67.01 |
| Enterprise Value (M USD) (ttm) | 1,079.36 |
| Enterprise Value/EBITDA (ttm) | 8.77 |
| Price/Book (mrq) | 2.2714 |
| Price/Sale (ttm) | 2.5725 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/02/2012 |
More IPXL Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for IPXL
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for IPXL
Impax Laboratories, Inc. develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. The Company specializes in the development of niche and controlled release generics, as well as the development of branded products.
| Robert L BurrChairman | Larry HsuPresident/CEO |
| Carole S Ben-MaimonPres:Global Pharmaceuticals | Michael J NestorPres:Impax Pharmaceuticals |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page